KRN330

· Kyowa Kirin, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for KRN330, covering 2015-03-23 to 2024-04-29. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study of KRN330 Monoclonal Antibody in Patients With Colorectal Cancer [Phase 1]